Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA101) (iFCG) for First-Line Treatment of Patients with CLL with Mutated IGHV and without TP53 Aberrations
Cigars and cigarettes differ in some ways
To receive further information, requests should be addressed to: Related health topic Related links Related team
Role: Site PI Project Number: R01NR018147-01 Name of PD/PI: Dagata, Amy PI *Source of Support: NIH (URI) *Title: Interpretation and Utility of Novel Composite Structural Endpoints of Cumulative Damage and Disease Activity in Knee Osteoarthritis This innovative project will use OAI data to demonstrate how much change in cumulative damage and disease activity composite metrics translates to clinically meaningful benefit (or worsening) from knee-specific and whole-person perspectives
Whether you are at home, work, or on the go, our mint-flavored pouches are discreet and easy to use
ZIMO Nicotine Pouches The semi-dry, water-free formula of Zimo gives ZYN a run for its money in absorption and might just have it beat in terms of flavor
